You are here: Industry Insights > Novavax

News List

SII postpones launch of Novavax vaccine in India expresspharma
March 29, 2021
Poonawalla said earlier this month that a temporary US ban on exports of critical raw materials could limit the production of coronavirus vaccines such as Novavax.
Wake Research Earns Recognition For Novavax COVID-19 Vaccine Trial, And As Top Clinical Service Provider Of 2021 prnewswire
March 19, 2021
Wake Research, an integrated national network of clinical investigative sites and one of North America's leading providers of Phase I-IV clinical trials, was recognized as a Top Enroller of patient volunteers by Novavax, a Maryland-based biotechnology ...
Novavax vaccine shows 96 per cent efficacy against original coronavirus, 86 per cent against UK variant expresspharma
March 15, 2021
Novavax plans to produce its two-shot vaccine at eight manufacturing locations, including the Serum Institute of India.
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials prnasia
March 12, 2021
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain in a pivotal Phase 3 ...
Novavax’s vaccine shows greater efficacy against Covid-19 variants pharmaceutical-technology
March 12, 2021
Novavax has reported that data from a pivotal Phase III trial of its vaccine candidate, NVX–CoV2373, in the UK showed an efficacy of 96.4% against mild, moderate and severe disease caused by the original Covid-19 strain.
Pfizer interested in producing vaccine in India if speedy clearance, export freedom assured: Reports expresspharma
March 11, 2021
Pfizer has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.
Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine contractpharma
March 10, 2021
New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.
Novavax concludes subject enrolment in Covid-19 vaccine trial pharmaceutical-technology
February 23, 2021
Biotechnology company Novavax has concluded enrolment in its pivotal Phase III PREVENT-19 study of Covid-19 vaccine candidate, NVX-CoV2373, in the US and Mexico.
FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site contractpharma
February 18, 2021
Billingham site to support the manufacture of up to 180 million doses Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.
Novavax, SK Bioscience Expand Vax Pact contractpharma
February 18, 2021
The existing partnership for manufacture of NVX-CoV2373 has been expanded to increase production capacity and supply vaccines to the Korean Government.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page